Italian Regulator Promotes Availability Of Potential COVID-19 Treatments
Remdesivir, Kaletra & Actemra Are In The Frame
Executive Summary
Italy has so far borne the brunt of Europe’s growing coronavirus outbreak. Now it is offering patients the chance to access unauthorized medicines as part of efforts to stem the outbreak.
You may also be interested in...
Where Now For Italy’s Drug Price Transparency Crusade?
The signs suggest that Nicola Magrini, the new director general of the Italian medicines regulator, AIFA, will follow in the footsteps of his predecessor in fighting for transparency in drug pricing.
WHO Launches Twin-Track Procedure To Speed Access To Health Products
A procedure used to accelerate the approval of COVID-19 products during the pandemic is to be applied to all medicines using “synchronized and parallel, but otherwise entirely independent, processes,” the World Health Organization says.
'Don't Compromise The Pharma Innovation System,' Says Outgoing IFPMA Head Thomas Cueni
Thomas Cueni is stepping down after seven years at the helm of the International Federation of Pharmaceutical Manufacturers and Associations. In an interview with the Pink Sheet ahead of his retirement, he reflects on the proposed pandemic treaty, what still needs to be done to ensure equitable access to medicines, the importance of tackling AMR, moves towards regulatory reliance – and what his post-IFPMA life might look like.